{
  "id": "map_1861",
  "title": "GLUCOCORTICOIDES\\N(GC)",
  "specialty": "EndocrinologÃ­a",
  "tag": "ğŸ“‹ GuÃ­a ClÃ­nica",
  "node_count": 317,
  "root": {
    "text": "GLUCOCORTICOIDES\\N(GC)",
    "children": [
      {
        "text": "â”œâ”€ DEFINICIÃ“N",
        "children": [
          {
            "text": "â”‚ â””â”€ Esteroide â†’ uniÃ³n receptor nuclear especÃ­fico (1)",
            "children": []
          }
        ]
      },
      {
        "text": "â”œâ”€ SÃNTESIS",
        "children": [
          {
            "text": "â”‚ â””â”€ BiosÃ­ntesis cortisol",
            "children": [
              {
                "text": "â”‚    â””â”€ Corteza suprarrenal â†’ colesterol + enzimas",
                "children": []
              }
            ]
          },
          {
            "text": "â”œâ”€ TIPOS",
            "children": [
              {
                "text": "â”‚ â”œâ”€ GC Naturales",
                "children": []
              },
              {
                "text": "â”‚ â””â”€ GC SintÃ©ticos",
                "children": [
                  {
                    "text": "â”‚    â”œâ”€ â†‘ potencia glucocorticoidea",
                    "children": [
                      {
                        "text": "â”‚    â”‚ â””â”€ Causas: â†‘vida media + â†‘afinidad receptor + â†“depuraciÃ³n plasmÃ¡tica",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "â”‚    â””â”€ ActivaciÃ³n",
                    "children": [
                      {
                        "text": "â”‚        â””â”€ HidroxilaciÃ³n hepÃ¡tica â†’ cortisol/prednisolona",
                        "children": []
                      }
                    ]
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "text": "â”œâ”€ FISIOLOGÃA",
        "children": [
          {
            "text": "â”‚ â”œâ”€ RegulaciÃ³n\\NsecreciÃ³n cortisol",
            "children": [
              {
                "text": "â”‚ â”‚ â”œâ”€ Ritmo circadiano (CRH hipotalÃ¡mico)",
                "children": []
              },
              {
                "text": "â”‚ â”‚ â”œâ”€ Feedback (-) ACTH y CRH",
                "children": []
              },
              {
                "text": "â”‚ â”‚ â””â”€ Respuesta estrÃ©s/dolor",
                "children": []
              }
            ]
          },
          {
            "text": "â”‚ â”œâ”€ Metabolismo",
            "children": [
              {
                "text": "â”‚ â”‚ â”œâ”€ Lugar: hÃ­gado",
                "children": []
              },
              {
                "text": "â”‚ â”‚ â””â”€ ExcreciÃ³n: renal (2)",
                "children": []
              }
            ]
          },
          {
            "text": "â”‚ â”œâ”€ UniÃ³n proteÃ­nas",
            "children": [
              {
                "text": "â”‚ â”‚ â”œâ”€ 90% â†’ CBG",
                "children": []
              },
              {
                "text": "â”‚ â”‚ â”œâ”€ 10% â†’ albÃºmina",
                "children": []
              },
              {
                "text": "â”‚ â”‚ â””â”€ FracciÃ³n libre = biolÃ³gicamente activa",
                "children": []
              }
            ]
          },
          {
            "text": "â”‚ â””â”€ Receptores",
            "children": [
              {
                "text": "â”‚     â”œâ”€ GR (receptor GC)",
                "children": []
              },
              {
                "text": "â”‚     â””â”€ MR (receptor mineralocorticoide)",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "text": "â””â”€ USO CLÃNICO",
        "children": [
          {
            "text": "â”œâ”€ IndicaciÃ³n â†’ antiinflamatorios potentes",
            "children": []
          },
          {
            "text": "â””â”€ Efectos adversos",
            "children": [
              {
                "text": "â””â”€ Tto prolongado/dosis â†‘ â†’ supresiÃ³n eje HHS",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "text": "â”œâ”€ REGULACIÃ“N\\NRECEPTOR MR",
        "children": [
          {
            "text": "â”‚ â”œâ”€ 11Î²HSD2 â†’ inactiva cortisol a cortisona",
            "children": []
          },
          {
            "text": "â”‚ â””â”€ Exceso cortisol (endÃ³geno/exÃ³geno) â†’ sobrepasa capacidad enzimÃ¡tica â†’ activa MR",
            "children": []
          }
        ]
      },
      {
        "text": "â”œâ”€ CLASIFICACIÃ“N GC",
        "children": [
          {
            "text": "â”‚ â”œâ”€ Origen: naturales/sintÃ©ticos",
            "children": []
          },
          {
            "text": "â”‚ â”œâ”€ Vida media",
            "children": []
          },
          {
            "text": "â”‚ â”œâ”€ Tiempo acciÃ³n: corto/intermedio/prolongado",
            "children": []
          },
          {
            "text": "â”‚ â””â”€ Potencia: gluco/mineralocorticoide",
            "children": []
          }
        ]
      },
      {
        "text": "â”œâ”€ EFECTOS",
        "children": [
          {
            "text": "â”‚ â”œâ”€ MetabÃ³licos",
            "children": [
              {
                "text": "â”‚ â”‚ â”œâ”€ â†‘ gluconeogÃ©nesis",
                "children": []
              },
              {
                "text": "â”‚ â”‚ â””â”€ â†“ secreciÃ³n insulina",
                "children": []
              }
            ]
          },
          {
            "text": "â”‚ â”œâ”€ CatabÃ³licos",
            "children": [
              {
                "text": "â”‚ â”‚ â”œâ”€ LÃ­pidos",
                "children": []
              },
              {
                "text": "â”‚ â”‚ â”œâ”€ MÃºsculos",
                "children": []
              },
              {
                "text": "â”‚ â”‚ â””â”€ Huesos",
                "children": []
              }
            ]
          },
          {
            "text": "â”‚ â””â”€ Sistema inmune (3)",
            "children": [
              {
                "text": "â”‚     â”œâ”€ â†“ migraciÃ³n cÃ©lulas inflamatorias",
                "children": []
              },
              {
                "text": "â”‚     â”œâ”€ â†“ producciÃ³n linfocitos",
                "children": []
              },
              {
                "text": "â”‚     â””â”€ â†“ sÃ­ntesis: prostaglandinas + IL-6 + TNF-Î±",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "text": "â””â”€ TERAPIA CRÃ“NICA",
        "children": [
          {
            "text": "â”œâ”€ Factores riesgo\\Ncomplicaciones",
            "children": [
              {
                "text": "â”‚ â”œâ”€ Dosis",
                "children": []
              },
              {
                "text": "â”‚ â”œâ”€ VÃ­a administraciÃ³n (oral = â†‘riesgo)",
                "children": []
              },
              {
                "text": "â”‚ â”œâ”€ DuraciÃ³n tratamiento",
                "children": []
              },
              {
                "text": "â”‚ â”œâ”€ CondiciÃ³n paciente",
                "children": []
              },
              {
                "text": "â”‚ â””â”€ Interacciones farmacolÃ³gicas",
                "children": []
              },
              {
                "text": "â””â”€ Esquema dÃ­as alternos (4-8)",
                "children": []
              }
            ]
          },
          {
            "text": "â”œâ”€ Ventaja: â†“supresiÃ³n eje H-H-S",
            "children": []
          },
          {
            "text": "â””â”€ Desventaja: â†“eficacia algunas patologÃ­as",
            "children": []
          }
        ]
      },
      {
        "text": "CLASIFICACIÃ“N Y\\NEFECTOS GC",
        "children": [
          {
            "text": "â”œâ”€ TIPOS GC\\N(segÃºn duraciÃ³n)",
            "children": [
              {
                "text": "â”‚ â”œâ”€ AcciÃ³n corta",
                "children": [
                  {
                    "text": "â”‚ â”‚ â”œâ”€ Cortisol: 20mg = potencia 1 (GC/MC) â†’ VM 80min â†’ AcciÃ³n 8-12h",
                    "children": []
                  },
                  {
                    "text": "â”‚ â”‚ â””â”€ Cortisona: 25mg = potencia 0.8 (GC/MC) â†’ VM 80min â†’ AcciÃ³n 6-12h",
                    "children": []
                  }
                ]
              },
              {
                "text": "â”‚ â”œâ”€ AcciÃ³n intermedia",
                "children": [
                  {
                    "text": "â”‚ â”‚ â”œâ”€ Prednisona/prednisolona: 5mg = potencia GC 4/MC 0.25 â†’ VM 60min â†’ AcciÃ³n 12-36h",
                    "children": []
                  },
                  {
                    "text": "â”‚ â”‚ â””â”€ Metilprednisolona: 4mg = potencia GC 4 â†’ VM 200min â†’ AcciÃ³n 12-36h",
                    "children": []
                  }
                ]
              },
              {
                "text": "â”‚ â””â”€ AcciÃ³n prolongada",
                "children": [
                  {
                    "text": "â”‚   â”œâ”€ Betametasona: 0.6mg = potencia GC 25 â†’ VM 300min â†’ AcciÃ³n 36-72h",
                    "children": []
                  },
                  {
                    "text": "â”‚   â””â”€ Dexametasona: 0.5mg = potencia GC 30 â†’ VM 300min â†’ AcciÃ³n 36-72h",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "â””â”€ EFECTOS\\NPOR SISTEMAS",
            "children": [
              {
                "text": "â”œâ”€ Metabolismo glÃºcido",
                "children": [
                  {
                    "text": "â”‚ â”œâ”€ Normal: mantiene glicemia ayuno/estrÃ©s",
                    "children": []
                  },
                  {
                    "text": "â”‚ â””â”€ Exceso: resistencia insulina â†’ DM",
                    "children": []
                  }
                ]
              },
              {
                "text": "â”œâ”€ PÃ¡ncreas",
                "children": [
                  {
                    "text": "â”‚ â”œâ”€ Normal: â†“secreciÃ³n insulina",
                    "children": []
                  },
                  {
                    "text": "â”‚ â””â”€ Exceso: disfunciÃ³n cÃ©lulas Î² â†’ hipoinsulinemia",
                    "children": []
                  }
                ]
              },
              {
                "text": "â”œâ”€ HÃ­gado",
                "children": [
                  {
                    "text": "â”‚ â”œâ”€ Normal: â†‘enzimas gluconeogÃ©nicas",
                    "children": []
                  },
                  {
                    "text": "â”‚ â””â”€ Exceso: â†‘glucosa + glucÃ³geno + hÃ­gado graso",
                    "children": []
                  }
                ]
              },
              {
                "text": "â”œâ”€ Tejido\\Ngraso/muscular",
                "children": [
                  {
                    "text": "â”‚ â”œâ”€ Normal: â†‘Ã¡cidos grasos/aminoÃ¡cidos â†’ gluconeogÃ©nesis",
                    "children": []
                  },
                  {
                    "text": "â”‚ â””â”€ Exceso: obesidad central\\N+ debilidad muscular",
                    "children": []
                  }
                ]
              },
              {
                "text": "â”œâ”€ Sistema inmune",
                "children": [
                  {
                    "text": "â”‚ â”œâ”€ Normal",
                    "children": [
                      {
                        "text": "â”‚ â”‚ â”œâ”€ â†“proliferaciÃ³n monocitos",
                        "children": []
                      },
                      {
                        "text": "â”‚ â”‚ â”œâ”€ â†“IL-1/IL-6/TNF-Î±",
                        "children": []
                      },
                      {
                        "text": "â”‚ â”‚ â””â”€ â†“inflamaciÃ³n",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "â”‚ â””â”€ Exceso: inmunosupresiÃ³n + linfopenia",
                    "children": []
                  }
                ]
              },
              {
                "text": "â”œâ”€ Eje HHS",
                "children": [
                  {
                    "text": "â”‚ â”œâ”€ Normal: â†“opioides\\N+ â†“FSH/LH/GnRH",
                    "children": []
                  },
                  {
                    "text": "â”‚ â””â”€ Exceso: alteraciones menstruales",
                    "children": []
                  }
                ]
              },
              {
                "text": "â””â”€ Otros sistemas",
                "children": [
                  {
                    "text": "â”œâ”€ Renal: â†“Ca++ â†’ hiperparatiroidismo 2Âº",
                    "children": []
                  },
                  {
                    "text": "â”œâ”€ Cardiovascular: â†‘contractilidad â†’ HTA",
                    "children": []
                  },
                  {
                    "text": "â”œâ”€ PsiquiÃ¡trico: euforia/depresiÃ³n + insomnio",
                    "children": []
                  },
                  {
                    "text": "â””â”€ Ã“seo: â†“colÃ¡geno â†’ osteoporosis",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "â”œâ”€ COMPROMISO\\NÃ“SEO (5)",
            "children": [
              {
                "text": "â”‚ â”œâ”€ EpidemiologÃ­a",
                "children": [
                  {
                    "text": "â”‚ â”‚ â”œâ”€ EA mÃ¡s frecuente",
                    "children": []
                  },
                  {
                    "text": "â”‚ â”‚ â””â”€ 50% pacientes crÃ³nicos â†’ osteoporosis (columna lumbar)",
                    "children": []
                  }
                ]
              },
              {
                "text": "â”‚ â”œâ”€ Factor riesgo",
                "children": [
                  {
                    "text": "â”‚ â”‚ â””â”€ Dosis >7.5 mg/d prednisona â†’ â†‘riesgo fracturas",
                    "children": []
                  }
                ]
              },
              {
                "text": "â”‚ â”œâ”€ PrevenciÃ³n (9)",
                "children": [
                  {
                    "text": "â”‚ â”‚ â”œâ”€ Ca++ 1000-1500 mg/d + VitD >800 UI/d",
                    "children": []
                  },
                  {
                    "text": "â”‚ â”‚ â”œâ”€ Actividad fÃ­sica mÃ¡xima posible",
                    "children": []
                  },
                  {
                    "text": "â”‚ â”‚ â”œâ”€ No tabaco/alcohol",
                    "children": []
                  },
                  {
                    "text": "â”‚ â”‚ â”œâ”€ Dosis GC mÃ­nima efectiva",
                    "children": []
                  },
                  {
                    "text": "â”‚ â”‚ â”œâ”€ DiurÃ©ticos tiazÃ­dicos si hipercalciuria",
                    "children": []
                  },
                  {
                    "text": "â”‚ â”‚ â””â”€ DensitometrÃ­a anual",
                    "children": []
                  }
                ]
              },
              {
                "text": "â”‚ â””â”€ Bisfosfonatos (9,10)",
                "children": [
                  {
                    "text": "â”‚     â”œâ”€ Riesgo bajo (<10%)",
                    "children": [
                      {
                        "text": "â”‚     â”‚ â””â”€ IndicaciÃ³n: prednisona >7.5mg/d >3 meses",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "â”‚     â”œâ”€ Riesgo medio (10-20%)",
                    "children": [
                      {
                        "text": "â”‚     â”‚ â””â”€ IndicaciÃ³n: GC >3 meses (cualquier dosis)",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "â”‚     â”œâ”€ Riesgo alto (>20%)",
                    "children": [
                      {
                        "text": "â”‚     â”‚ â”œâ”€ IndicaciÃ³n: siempre",
                        "children": []
                      },
                      {
                        "text": "â”‚     â”‚ â””â”€ Alternativa: teriparatide (â†‘costo)",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "â”‚     â””â”€ Mujeres premenopÃ¡usicas",
                    "children": [
                      {
                        "text": "â”‚         â””â”€ IndicaciÃ³n: pÃ©rdida Ã³sea >4%/aÃ±o + prednisona >7.5mg/d >3 meses",
                        "children": []
                      }
                    ]
                  }
                ]
              }
            ]
          },
          {
            "text": "â”œâ”€ NECROSIS Ã“SEA\\NAVASCULAR CADERA (11)",
            "children": [
              {
                "text": "â”‚ â”œâ”€ PoblaciÃ³n: jÃ³venes + dosis altas",
                "children": []
              },
              {
                "text": "â”‚ â””â”€ DiagnÃ³stico: RNM precoz",
                "children": []
              }
            ]
          },
          {
            "text": "â””â”€ MIOPATÃA (12,13)",
            "children": [
              {
                "text": "â”œâ”€ ClÃ­nica",
                "children": [
                  {
                    "text": "â”‚ â””â”€ Debilidad simÃ©trica proximal (EESS/EEII)",
                    "children": []
                  }
                ]
              },
              {
                "text": "â”œâ”€ Laboratorio",
                "children": [
                  {
                    "text": "â”‚ â”œâ”€ Enzimas musculares normales",
                    "children": []
                  },
                  {
                    "text": "â”‚ â””â”€ EMG: patrÃ³n miopÃ¡tico",
                    "children": []
                  }
                ]
              },
              {
                "text": "â””â”€ Tratamiento",
                "children": [
                  {
                    "text": "â”œâ”€ â†“dosis GC",
                    "children": []
                  },
                  {
                    "text": "â”œâ”€ Ejercicios preventivos",
                    "children": []
                  },
                  {
                    "text": "â””â”€ Cambio a GC no fluorados\\N(prednisona/hidrocortisona)",
                    "children": []
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "text": "OTROS EFECTOS\\NADVERSOS GC",
        "children": [
          {
            "text": "â”œâ”€ INFECCIONES",
            "children": [
              {
                "text": "â”‚ â”œâ”€ Factores riesgo",
                "children": [
                  {
                    "text": "â”‚ â”‚ â”œâ”€ â†“inmunidad celular",
                    "children": []
                  },
                  {
                    "text": "â”‚ â”‚ â””â”€ â†“funciÃ³n fagocitos/neutrÃ³filos",
                    "children": []
                  }
                ]
              },
              {
                "text": "â”‚ â”œâ”€ NeumonÃ­a\\NPneumocystis",
                "children": [
                  {
                    "text": "â”‚ â”‚ â”œâ”€ Riesgo: prednisona >10mg/d",
                    "children": []
                  },
                  {
                    "text": "â”‚ â”‚ â””â”€ Profilaxis: TMP/SMX\\N800/160mg 3x/sem",
                    "children": [
                      {
                        "text": "â”‚ â”‚     â””â”€ Indicaciones (14)",
                        "children": [
                          {
                            "text": "â”‚ â”‚         â”œâ”€ Trasplante Ã³rganos sÃ³lidos/hematolÃ³gicos",
                            "children": []
                          },
                          {
                            "text": "â”‚ â”‚         â”œâ”€ Enfermedades neurolÃ³gicas asociadas",
                            "children": []
                          },
                          {
                            "text": "â”‚ â”‚         â””â”€ Enfermedad Wegener",
                            "children": []
                          }
                        ]
                      }
                    ]
                  }
                ]
              }
            ]
          },
          {
            "text": "â”œâ”€ GASTROINTESTINALES (8,15)",
            "children": [
              {
                "text": "â”‚ â”œâ”€ â†‘Riesgo Ãºlcera pÃ©ptica",
                "children": [
                  {
                    "text": "â”‚ â”‚ â””â”€ Factores: +AINE/antecedente sangrado/anticoagulantes",
                    "children": []
                  }
                ]
              },
              {
                "text": "â”‚ â””â”€ PrevenciÃ³n: IBP si GC+AINE/factores riesgo",
                "children": []
              }
            ]
          },
          {
            "text": "â”œâ”€ CARDIOVASCULARES (16,17)",
            "children": [
              {
                "text": "â”‚ â”œâ”€ â†‘Riesgo proporcional a dosis (RR 4.5 dosis altas)",
                "children": []
              },
              {
                "text": "â”‚ â”œâ”€ Mecanismo: receptores GC+MC",
                "children": []
              },
              {
                "text": "â”‚ â””â”€ â†“Riesgo: dÃ­as alternos/dosis bajas",
                "children": []
              }
            ]
          },
          {
            "text": "â”œâ”€ DERMATOLÃ“GICOS (17)",
            "children": [
              {
                "text": "â”‚ â”œâ”€ Dosis >5mg/d prednisona",
                "children": [
                  {
                    "text": "â”‚ â”‚ â”œâ”€ Adelgazamiento piel",
                    "children": []
                  },
                  {
                    "text": "â”‚ â”‚ â”œâ”€ EstrÃ­as",
                    "children": []
                  },
                  {
                    "text": "â”‚ â”‚ â”œâ”€ AcnÃ©",
                    "children": []
                  },
                  {
                    "text": "â”‚ â”‚ â”œâ”€ RosÃ¡cea",
                    "children": []
                  },
                  {
                    "text": "â”‚ â”‚ â”œâ”€ Telangiectasias",
                    "children": []
                  },
                  {
                    "text": "â”‚ â”‚ â””â”€ Facies cushingoide",
                    "children": []
                  }
                ]
              },
              {
                "text": "â”‚ â””â”€ â†‘Riesgo cÃ¡ncer piel no melanoma",
                "children": []
              }
            ]
          },
          {
            "text": "â”œâ”€ OCULARES",
            "children": [
              {
                "text": "â”‚ â”œâ”€ Catarata subcapsular posterior",
                "children": [
                  {
                    "text": "â”‚ â”‚ â””â”€ No relacionada dosis/vÃ­a administraciÃ³n",
                    "children": []
                  }
                ]
              },
              {
                "text": "â”‚ â””â”€ Glaucoma",
                "children": [
                  {
                    "text": "â”‚     â””â”€ Riesgo âˆ dosis + susceptibilidad genÃ©tica",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "â”œâ”€ SNC (18-20)",
            "children": [
              {
                "text": "â”‚ â”œâ”€ Dosis >5mg/d prednisona >1mes",
                "children": [
                  {
                    "text": "â”‚ â”‚ â””â”€ AlteraciÃ³n hipocampo â†’ deterioro memoria",
                    "children": []
                  }
                ]
              },
              {
                "text": "â”‚ â”œâ”€ Inicio: euforia",
                "children": []
              },
              {
                "text": "â”‚ â””â”€ CrÃ³nico",
                "children": [
                  {
                    "text": "â”‚     â”œâ”€ DepresiÃ³n (10%)",
                    "children": []
                  },
                  {
                    "text": "â”‚     â”œâ”€ HipomanÃ­a (30%)",
                    "children": []
                  },
                  {
                    "text": "â”‚     â””â”€ Psicosis (tambiÃ©n pulsos agudos altas dosis)",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "â””â”€ EJE HHS (21)",
            "children": [
              {
                "text": "â”œâ”€ SupresiÃ³n: prednisona >5mg/d >2sem",
                "children": []
              },
              {
                "text": "â””â”€ Mecanismo",
                "children": [
                  {
                    "text": "â”œâ”€ â†“CRH hipotalÃ¡mico",
                    "children": []
                  },
                  {
                    "text": "â”œâ”€ â†“ACTH hipofisaria",
                    "children": []
                  },
                  {
                    "text": "â””â”€ Atrofia corteza suprarrenal (zonas fascicular/reticular)",
                    "children": []
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "text": "ALTERACIONES METABÃ“LICAS Y\\NSUPRESIÃ“N EJE HHS",
        "children": [
          {
            "text": "â”œâ”€ METABOLISMO\\NGLUCOSA (3,17,22-25)",
            "children": [
              {
                "text": "â”‚ â”œâ”€ Mecanismos\\Nhiperglicemia",
                "children": [
                  {
                    "text": "â”‚ â”‚ â”œâ”€ â†‘gluconeogÃ©nesis hepÃ¡tica",
                    "children": []
                  },
                  {
                    "text": "â”‚ â”‚ â”œâ”€ â†‘respuesta hepÃ¡tica glucagÃ³n",
                    "children": []
                  },
                  {
                    "text": "â”‚ â”‚ â”œâ”€ â†“ingreso glucosa mÃºsculo/adiposo",
                    "children": []
                  },
                  {
                    "text": "â”‚ â”‚ â””â”€ DaÃ±o cÃ©lula Î² (lipotoxicidad)",
                    "children": []
                  }
                ]
              },
              {
                "text": "â”‚ â”œâ”€ Riesgo\\NDM esteroidal",
                "children": [
                  {
                    "text": "â”‚ â”‚ â”œâ”€ RR 8.9: prednisona <10mg/d",
                    "children": []
                  },
                  {
                    "text": "â”‚ â”‚ â””â”€ RR 10.3: prednisona >30mg/d",
                    "children": []
                  }
                ]
              },
              {
                "text": "â”‚ â”œâ”€ Factores riesgo",
                "children": [
                  {
                    "text": "â”‚ â”‚ â”œâ”€ Edad avanzada",
                    "children": []
                  },
                  {
                    "text": "â”‚ â”‚ â””â”€ Obesidad",
                    "children": []
                  }
                ]
              },
              {
                "text": "â”‚ â””â”€ Manejo: similar DM/hiperglicemia no esteroidal",
                "children": []
              }
            ]
          },
          {
            "text": "â””â”€ SUPRESIÃ“N\\NEJE HHS (26)",
            "children": [
              {
                "text": "â”œâ”€ Consideraciones suspensiÃ³n GC",
                "children": [
                  {
                    "text": "â”‚ â”œâ”€ Riesgo reactivaciÃ³n enfermedad base",
                    "children": []
                  },
                  {
                    "text": "â”‚ â””â”€ Riesgo insuficiencia suprarrenal 2Âª",
                    "children": []
                  }
                ]
              },
              {
                "text": "â”œâ”€ RecuperaciÃ³n eje",
                "children": [
                  {
                    "text": "â”‚ â”œâ”€ MayorÃ­a: semanas-meses",
                    "children": []
                  },
                  {
                    "text": "â”‚ â””â”€ Algunos: hasta 1 aÃ±o",
                    "children": []
                  }
                ]
              },
              {
                "text": "â””â”€ Grupos riesgo",
                "children": [
                  {
                    "text": "â”œâ”€ ALTO",
                    "children": [
                      {
                        "text": "â”‚ â””â”€ Criterios",
                        "children": [
                          {
                            "text": "â”‚     â”œâ”€ Prednisona >20mg/d >2sem",
                            "children": []
                          },
                          {
                            "text": "â”‚     â”œâ”€ GC vespertinos/noche >1sem",
                            "children": []
                          },
                          {
                            "text": "â”‚     â””â”€ Fenotipo cushingoideo",
                            "children": []
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "text": "â”œâ”€ INTERMEDIO",
                    "children": [
                      {
                        "text": "â”‚ â””â”€ Criterios",
                        "children": [
                          {
                            "text": "â”‚     â”œâ”€ Prednisona 7. 5-20mg/d >2-3sem",
                            "children": []
                          },
                          {
                            "text": "â”‚     â””â”€ Riesgo alto ISR aguda (ej: cirugÃ­a)",
                            "children": []
                          }
                        ]
                      }
                    ]
                  },
                  {
                    "text": "â””â”€ BAJO",
                    "children": [
                      {
                        "text": "â””â”€ Criterios",
                        "children": [
                          {
                            "text": "â”œâ”€ GC <2-3sem (cualquier dosis)",
                            "children": []
                          },
                          {
                            "text": "â””â”€ GC dÃ­as alternos",
                            "children": [
                              {
                                "text": "â””â”€ SuspensiÃ³n segura 72h",
                                "children": []
                              }
                            ]
                          }
                        ]
                      }
                    ]
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "text": "EVALUACIÃ“N FUNCIÃ“N EJE\\NHHS Y SUSPENSIÃ“N GC",
        "children": [
          {
            "text": "â”œâ”€ CORTISOL MATINAL\\N(21,26)",
            "children": [
              {
                "text": "â”‚ â”œâ”€ Indicaciones",
                "children": [
                  {
                    "text": "â”‚ â”‚ â””â”€ Riesgo intermedio + GC bajas dosis <2sem + â†“gradual hasta 5-7.5mg/d",
                    "children": []
                  }
                ]
              },
              {
                "text": "â”‚ â””â”€ InterpretaciÃ³n",
                "children": [
                  {
                    "text": "â”‚     â”œâ”€ <5 Âµg/dL â†’ insuficiencia suprarrenal",
                    "children": []
                  },
                  {
                    "text": "â”‚     â””â”€ >15 Âµg/dL â†’ recuperaciÃ³n eje",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "â”œâ”€ TEST\\NESTÃMULO ACTH",
            "children": [
              {
                "text": "â”‚ â”œâ”€ Indicaciones",
                "children": [
                  {
                    "text": "â”‚ â”‚ â”œâ”€ Alto riesgo insuficiencia suprarrenal",
                    "children": []
                  },
                  {
                    "text": "â”‚ â”‚ â””â”€ Riesgo incierto + cortisol matinal dudoso",
                    "children": []
                  }
                ]
              },
              {
                "text": "â”‚ â”œâ”€ Contraindicaciones",
                "children": [
                  {
                    "text": "â”‚ â”‚ â””â”€ ACO/THR menopausia",
                    "children": [
                      {
                        "text": "â”‚ â”‚     â””â”€ EstrÃ³genos â†’ â†‘CBG â†’ alteraciÃ³n cortisol",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "â”‚ â””â”€ TÃ©cnica",
                    "children": [
                      {
                        "text": "â”‚     â”œâ”€ Suspender GC 24h antes",
                        "children": []
                      },
                      {
                        "text": "â”‚     â”œâ”€ ACTH (Synacthen) 250Âµg IM 09:00h",
                        "children": []
                      },
                      {
                        "text": "â”‚     â””â”€ Cortisol 60min post-ACTH",
                        "children": [
                          {
                            "text": "â”‚         â””â”€ ISR si <15-18 Âµg/dL (S:97.5%)",
                            "children": []
                          }
                        ]
                      }
                    ]
                  }
                ]
              }
            ]
          },
          {
            "text": "â””â”€ SUSPENSIÃ“N\\NTRATAMIENTO",
            "children": [
              {
                "text": "â””â”€ Indicaciones",
                "children": [
                  {
                    "text": "â”œâ”€ No beneficio terapÃ©utico esperado",
                    "children": []
                  },
                  {
                    "text": "â”œâ”€ EA graves/incontrolables",
                    "children": [
                      {
                        "text": "â”‚ â”œâ”€ Osteoporosis lumbar",
                        "children": []
                      },
                      {
                        "text": "â”‚ â””â”€ HipertensiÃ³n",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "â””â”€ Complicaciones graves",
                    "children": [
                      {
                        "text": "â”œâ”€ Psicosis aguda resistente",
                        "children": []
                      },
                      {
                        "text": "â””â”€ Ãšlcera corneal herpÃ©tica â†’ riesgo perforaciÃ³n/ceguera",
                        "children": []
                      }
                    ]
                  }
                ]
              }
            ]
          },
          {
            "text": "â”œâ”€ COMPLICACIONES\\NSUSPENSIÃ“N (21)",
            "children": [
              {
                "text": "â”‚ â”œâ”€ ISR 2Âª",
                "children": []
              },
              {
                "text": "â”‚ â”œâ”€ RecaÃ­da enfermedad base",
                "children": []
              },
              {
                "text": "â”‚ â””â”€ SÃ­ndrome privaciÃ³n",
                "children": [
                  {
                    "text": "â”‚     â”œâ”€ Cansancio",
                    "children": []
                  },
                  {
                    "text": "â”‚     â”œâ”€ Fatigabilidad",
                    "children": []
                  },
                  {
                    "text": "â”‚     â”œâ”€ Anorexia",
                    "children": []
                  },
                  {
                    "text": "â”‚     â””â”€ Trastornos Ã¡nimo",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "â”œâ”€ CONSIDERACIONES\\NRETIRO (21,27)",
            "children": [
              {
                "text": "â”‚ â”œâ”€ Factores\\Nindividuales",
                "children": [
                  {
                    "text": "â”‚ â”‚ â”œâ”€ Edad",
                    "children": []
                  },
                  {
                    "text": "â”‚ â”‚ â”œâ”€ Fragilidad",
                    "children": []
                  },
                  {
                    "text": "â”‚ â”‚ â”œâ”€ Comorbilidades",
                    "children": []
                  },
                  {
                    "text": "â”‚ â”‚ â”œâ”€ Riesgo recurrencia",
                    "children": []
                  },
                  {
                    "text": "â”‚ â”‚ â”œâ”€ Factores psicolÃ³gicos",
                    "children": []
                  },
                  {
                    "text": "â”‚ â”‚ â””â”€ DuraciÃ³n previa GC",
                    "children": []
                  }
                ]
              },
              {
                "text": "â”‚ â””â”€ Dosis segura suspensiÃ³n",
                "children": [
                  {
                    "text": "â”‚     â””â”€ Prednisona <5mg/d â†’ baja probabilidad supresiÃ³n HHS",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "text": "â””â”€\\NRECOMENDACIONES\\NESPECÃFICAS",
            "children": [
              {
                "text": "â”œâ”€ GC >2-3sem",
                "children": [
                  {
                    "text": "â”‚ â””â”€ Reducir hasta prednisona 5mg/d (=20mg/d hidrocortisona)",
                    "children": []
                  }
                ]
              },
              {
                "text": "â”œâ”€ Esquema reducciÃ³n\\NsegÃºn dosis inicial",
                "children": [
                  {
                    "text": "â”‚ â”œâ”€ >60mg/d â†’ â†“10mg/sem",
                    "children": []
                  },
                  {
                    "text": "â”‚ â”œâ”€ 20-60mg/d â†’ â†“5mg/sem",
                    "children": []
                  },
                  {
                    "text": "â”‚ â””â”€ 5-20mg/d â†’ â†“2.5mg/sem",
                    "children": []
                  }
                ]
              },
              {
                "text": "â”œâ”€ MonitorizaciÃ³n 1\\Nmes con 5mg/d",
                "children": [
                  {
                    "text": "â”‚ â”œâ”€ Si cortisol <5Âµg/dL â†’ mantener GC",
                    "children": []
                  },
                  {
                    "text": "â”‚ â”œâ”€ Si cortisol >15Âµg/dL â†’ suspender",
                    "children": []
                  },
                  {
                    "text": "â”‚ â””â”€ Si cortisol 5-15Âµg/dL â†’ test ACTH",
                    "children": []
                  }
                ]
              },
              {
                "text": "â”œâ”€ Alternativa:\\NdÃ­as alternos",
                "children": [
                  {
                    "text": "â”‚ â””â”€ Ãštil si estables\\N+ ya en 5mg/d",
                    "children": []
                  },
                  {
                    "text": "â””â”€ Sin test ACTH disponible",
                    "children": [
                      {
                        "text": "â””â”€ Considerar eje suprimido 1 aÃ±o post-suspensiÃ³n",
                        "children": []
                      }
                    ]
                  }
                ]
              },
              {
                "text": "â””â”€ Suplementar\\Nhidrocortisona si:",
                "children": [
                  {
                    "text": "â”œâ”€ CirugÃ­a",
                    "children": []
                  },
                  {
                    "text": "â””â”€ InfecciÃ³n",
                    "children": []
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "text": "ALGORITMO SUSPENSIÃ“N GC Y\\NEDUCACIÃ“N PACIENTE",
        "children": [
          {
            "text": "â”œâ”€ ALGORITMO\\NSUSPENSIÃ“N GC",
            "children": [
              {
                "text": "â”‚ â”œâ”€ GC <2sem",
                "children": [
                  {
                    "text": "â”‚ â”‚ â””â”€\\NSuspensiÃ³n\\Ndirecta",
                    "children": []
                  },
                  {
                    "text": "â”‚ â”‚     â””â”€ Riesgo bajo\\NsupresiÃ³n HHS",
                    "children": []
                  }
                ]
              },
              {
                "text": "â”‚ â””â”€ GC >3sem",
                "children": [
                  {
                    "text": "â”‚     â”œâ”€\\NPrednisona 5-7.\\N5mg/d",
                    "children": [
                      {
                        "text": "â”‚     â”‚ â””â”€ Riesgo\\Nintermedio/incierto",
                        "children": []
                      },
                      {
                        "text": "â”‚     â”‚     â””â”€ Evaluar:\\Ncortisol basal matinal",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "â”‚     â”œâ”€\\NPrednisona\\N>10mg/d",
                    "children": [
                      {
                        "text": "â”‚     â”‚ â””â”€ Riesgo alto",
                        "children": []
                      },
                      {
                        "text": "â”‚     â”‚     â””â”€\\NEvaluar: test ACTH",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "â”‚     â””â”€ DecisiÃ³n\\NsegÃºn cortisol",
                    "children": [
                      {
                        "text": "â”‚         â”œâ”€ <5Âµg/dL",
                        "children": [
                          {
                            "text": "â”‚         â”‚ â””â”€ Mantener\\NGC + control 1 mes",
                            "children": []
                          }
                        ]
                      },
                      {
                        "text": "â”‚         â”œâ”€ 5-15Âµg/dL",
                        "children": [
                          {
                            "text": "â”‚         â”‚ â””â”€ Test\\NACTH o dÃ­as alternos",
                            "children": []
                          }
                        ]
                      },
                      {
                        "text": "â”‚         â””â”€ >15Âµg/dL",
                        "children": [
                          {
                            "text": "â”‚             â””â”€\\NSuspender GC",
                            "children": []
                          }
                        ]
                      }
                    ]
                  }
                ]
              }
            ]
          },
          {
            "text": "â””â”€ EDUCACIÃ“N\\NPACIENTE CRÃ“NICO",
            "children": [
              {
                "text": "â”œâ”€ IdentificaciÃ³n",
                "children": [
                  {
                    "text": "â”‚ â””â”€\\NMedalla/pulsera\\Nusuario GC",
                    "children": []
                  }
                ]
              },
              {
                "text": "â””â”€ EducaciÃ³n\\Npaciente/familia",
                "children": [
                  {
                    "text": "â”œâ”€ Importancia\\Nadherencia",
                    "children": []
                  },
                  {
                    "text": "â”œâ”€ Ajuste dosis",
                    "children": [
                      {
                        "text": "â”‚ â””â”€ Situaciones estrÃ©s",
                        "children": []
                      },
                      {
                        "text": "â”‚     â”œâ”€ Fiebre",
                        "children": []
                      },
                      {
                        "text": "â”‚     â”œâ”€ CirugÃ­a",
                        "children": []
                      },
                      {
                        "text": "â”‚     â””â”€ Trauma",
                        "children": []
                      }
                    ]
                  },
                  {
                    "text": "â””â”€ SÃ­ntomas alarma",
                    "children": [
                      {
                        "text": "â”œâ”€ VÃ³mitos",
                        "children": []
                      },
                      {
                        "text": "â””â”€ Diarrea",
                        "children": [
                          {
                            "text": "â””â”€ Consulta urgencia\\Nâ†’ GC parenteral",
                            "children": []
                          }
                        ]
                      }
                    ]
                  }
                ]
              }
            ]
          }
        ]
      }
    ]
  },
  "related_maps": [
    {
      "id": "map_1668",
      "title": "HORIZON-RFT (2007)\\NHealth Outcomes and Reduced\\NIncidence with Zoledronic Acid\\NOnce Yearly - Recurrent Fracture Trial\\N\\Nâ­ Zoledronato post fractura cadera\\Nreduce refracturas Y mortalidad"
    },
    {
      "id": "map_1689",
      "title": "SPRINTT (2021)\\NSarcopenia and Physical\\NFragility in Older People:\\NMulti-component Treatment\\N\\nâ­ Ejercicio + nutriciÃ³n reduce\\ndiscapacidad en fragilidad fÃ­sica\\ncon sarcopenia"
    },
    {
      "id": "map_1740",
      "title": "FOCUS (2011)\\NFunctional Outcomes in\\NCardiovascular patients\\nUndergoing Surgical\\nhip fracture repair\\N\\nâ­ TransfusiÃ³n restrictiva (Hb menor 8)\\Nno inferior a liberal (Hb menor 10)\\Nen fractura cadera con riesgo CV"
    },
    {
      "id": "map_1671",
      "title": "ICE-FRAIL (2024)\\N\\nâ­ Fragilidad predice mortalidad UCI\\N\\nCFS mejor que APACHE/SOFA solos"
    },
    {
      "id": "map_1673",
      "title": "DAPA-CKD (2020)\\NDapagliflozin And Prevention\\Nof Adverse outcomes in CKD\\N\\Nâ­ iSGLT2 protege riÃ±Ã³n\\NINCLUSO SIN DIABETES\\N(Extiende beneficio a ERC no-DM)"
    }
  ],
  "source_file": "Arteaga | Glucocorticoides-2024.smmx",
  "created": "2026-02-07T15:43:01.655387"
}